StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 01 Sep 2026 07:36:40 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Chardan Assumes Rocket Pharmaceuticals (RCKT) at Buy http://www.streetinsider.com/Hot+New+Coverage/Chardan+Assumes+Rocket+Pharmaceuticals+%28RCKT%29+at+Buy/27008909.html (Updated - September 1, 2026 7:36 AM EDT) <p>Chardan analyst Keay Nakae assumes coverage on Rocket Pharmaceuticals (NASDAQ: RCKT) with a Buy rating and a price target of $11.00.</p><p>The analyst comments "We are transferring coverage of Rocket Pharmaceuticals (RCKT) to Keay Nakae, CFA. We maintain our Buy rating and $11 price target. Rocket is a soon-to-be commercial-stage gene therapy company with three AAV-based cardiovascular programs in clinical development and Kresladi, its FDA-approved ex vivo lentiviral gene therapy for severe leukocyte adhesion deficiency-I (LAD-I). The $180 million monetization of the Kresladi Priority Review Voucher, which closed in June 2026, left the company http://www.streetinsider.com/Hot+New+Coverage/Chardan+Assumes+Rocket+Pharmaceuticals+%28RCKT%29+at+Buy/27008909.html Tue, 01 Sep 2026 07:36:40 -0400 RCKT Chardan Assumes Rocket Pharmaceuticals (RCKT) at Buy http://www.streetinsider.com/New+Coverage/Chardan+Assumes+Rocket+Pharmaceuticals+%28RCKT%29+at+Buy/27008909.html (Updated - September 1, 2026 7:36 AM EDT) <p>Chardan analyst Keay Nakae assumes coverage on Rocket Pharmaceuticals (NASDAQ: RCKT) with a Buy rating and a price target of $11.00.</p><p>The analyst comments "We are transferring coverage of Rocket Pharmaceuticals (RCKT) to Keay Nakae, CFA. We maintain our Buy rating and $11 price target. Rocket is a soon-to-be commercial-stage gene therapy company with three AAV-based cardiovascular programs in clinical development and Kresladi, its FDA-approved ex vivo lentiviral gene therapy for severe leukocyte adhesion deficiency-I (LAD-I). The $180 million monetization of the Kresladi Priority Review Voucher, which closed in June 2026, left the company http://www.streetinsider.com/New+Coverage/Chardan+Assumes+Rocket+Pharmaceuticals+%28RCKT%29+at+Buy/27008909.html Tue, 01 Sep 2026 07:36:40 -0400 RCKT Chardan Assumes Rocket Pharmaceuticals (RCKT) at Buy http://www.streetinsider.com/Analyst+Comments/Chardan+Assumes+Rocket+Pharmaceuticals+%28RCKT%29+at+Buy/27008909.html (Updated - September 1, 2026 7:36 AM EDT) <p>Chardan analyst Keay Nakae assumes coverage on Rocket Pharmaceuticals (NASDAQ: RCKT) with a Buy rating and a price target of $11.00.</p><p>The analyst comments "We are transferring coverage of Rocket Pharmaceuticals (RCKT) to Keay Nakae, CFA. We maintain our Buy rating and $11 price target. Rocket is a soon-to-be commercial-stage gene therapy company with three AAV-based cardiovascular programs in clinical development and Kresladi, its FDA-approved ex vivo lentiviral gene therapy for severe leukocyte adhesion deficiency-I (LAD-I). The $180 million monetization of the Kresladi Priority Review Voucher, which closed in June 2026, left the company http://www.streetinsider.com/Analyst+Comments/Chardan+Assumes+Rocket+Pharmaceuticals+%28RCKT%29+at+Buy/27008909.html Tue, 01 Sep 2026 07:36:40 -0400 RCKT Chardan Assumes Rocket Pharmaceuticals (RCKT) at Buy http://www.streetinsider.com/Hot+Comments/Chardan+Assumes+Rocket+Pharmaceuticals+%28RCKT%29+at+Buy/27008909.html (Updated - September 1, 2026 7:36 AM EDT) <p>Chardan analyst Keay Nakae assumes coverage on Rocket Pharmaceuticals (NASDAQ: RCKT) with a Buy rating and a price target of $11.00.</p><p>The analyst comments "We are transferring coverage of Rocket Pharmaceuticals (RCKT) to Keay Nakae, CFA. We maintain our Buy rating and $11 price target. Rocket is a soon-to-be commercial-stage gene therapy company with three AAV-based cardiovascular programs in clinical development and Kresladi, its FDA-approved ex vivo lentiviral gene therapy for severe leukocyte adhesion deficiency-I (LAD-I). The $180 million monetization of the Kresladi Priority Review Voucher, which closed in June 2026, left the company http://www.streetinsider.com/Hot+Comments/Chardan+Assumes+Rocket+Pharmaceuticals+%28RCKT%29+at+Buy/27008909.html Tue, 01 Sep 2026 07:36:40 -0400 RCKT Form 8-K ROCKET PHARMACEUTICALS, For: Aug 21 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+21/26989870.html si-local-file:///var/storage/secattach/20260827/26989870.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+21/26989870.html Thu, 27 Aug 2026 16:06:00 -0400 O.00056691 RCKT Form 8-K ROCKET PHARMACEUTICALS, For: Aug 21 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+21/26989870.html si-local-file:///var/storage/secattach/20260827/26989870.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+21/26989870.html Thu, 27 Aug 2026 16:06:00 -0400 O.00056691 RCKT Form 4 ROCKET PHARMACEUTICALS, For: Aug 18 Filed by: Wilson Martin http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+18++Filed+by%3A+Wilson+Martin/26957275.html si-local-file:///var/storage/secattach/20260820/26957275.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+18++Filed+by%3A+Wilson+Martin/26957275.html Thu, 20 Aug 2026 17:30:00 -0400 O.00056691 RCKT Form 4 ROCKET PHARMACEUTICALS, For: Aug 18 Filed by: Wilson Martin http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+18++Filed+by%3A+Wilson+Martin/26957275.html si-local-file:///var/storage/secattach/20260820/26957275.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+18++Filed+by%3A+Wilson+Martin/26957275.html Thu, 20 Aug 2026 17:30:00 -0400 O.00056691 RCKT Form 4 ROCKET PHARMACEUTICALS, For: Aug 18 Filed by: Shah Gaurav http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+18++Filed+by%3A+Shah+Gaurav/26957243.html si-local-file:///var/storage/secattach/20260820/26957243.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+18++Filed+by%3A+Shah+Gaurav/26957243.html Thu, 20 Aug 2026 17:26:00 -0400 O.00056691 RCKT Form 4 ROCKET PHARMACEUTICALS, For: Aug 18 Filed by: Shah Gaurav http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+18++Filed+by%3A+Shah+Gaurav/26957243.html si-local-file:///var/storage/secattach/20260820/26957243.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+18++Filed+by%3A+Shah+Gaurav/26957243.html Thu, 20 Aug 2026 17:26:00 -0400 O.00056691 RCKT Form 144 ROCKET PHARMACEUTICALS, Filed by: Shah Gaurav http://www.streetinsider.com/SEC+Filings/Form++144++++++++ROCKET+PHARMACEUTICALS%2C++++++++++++++++Filed+by%3A+Shah+Gaurav/26943959.html si-local-file:///var/storage/secattach/20260818/26943959.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++ROCKET+PHARMACEUTICALS%2C++++++++++++++++Filed+by%3A+Shah+Gaurav/26943959.html Tue, 18 Aug 2026 15:50:00 -0400 O.00056691 RCKT Form 144 ROCKET PHARMACEUTICALS, Filed by: Shah Gaurav http://www.streetinsider.com/SEC+Filings/Form++144++++++++ROCKET+PHARMACEUTICALS%2C++++++++++++++++Filed+by%3A+Shah+Gaurav/26943959.html si-local-file:///var/storage/secattach/20260818/26943959.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++ROCKET+PHARMACEUTICALS%2C++++++++++++++++Filed+by%3A+Shah+Gaurav/26943959.html Tue, 18 Aug 2026 15:50:00 -0400 O.00056691 RCKT Form 144 ROCKET PHARMACEUTICALS, Filed by: Wilson Martin http://www.streetinsider.com/SEC+Filings/Form++144++++++++ROCKET+PHARMACEUTICALS%2C++++++++++++++++Filed+by%3A+Wilson+Martin/26943950.html si-local-file:///var/storage/secattach/20260818/26943950.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++ROCKET+PHARMACEUTICALS%2C++++++++++++++++Filed+by%3A+Wilson+Martin/26943950.html Tue, 18 Aug 2026 15:47:00 -0400 O.00056691 RCKT Form 144 ROCKET PHARMACEUTICALS, Filed by: Wilson Martin http://www.streetinsider.com/SEC+Filings/Form++144++++++++ROCKET+PHARMACEUTICALS%2C++++++++++++++++Filed+by%3A+Wilson+Martin/26943950.html si-local-file:///var/storage/secattach/20260818/26943950.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++ROCKET+PHARMACEUTICALS%2C++++++++++++++++Filed+by%3A+Wilson+Martin/26943950.html Tue, 18 Aug 2026 15:47:00 -0400 O.00056691 RCKT Form 144 ROCKET PHARMACEUTICALS, Filed by: Militello John http://www.streetinsider.com/SEC+Filings/Form++144++++++++ROCKET+PHARMACEUTICALS%2C++++++++++++++++Filed+by%3A+Militello+John/26943923.html si-local-file:///var/storage/secattach/20260818/26943923.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++ROCKET+PHARMACEUTICALS%2C++++++++++++++++Filed+by%3A+Militello+John/26943923.html Tue, 18 Aug 2026 15:44:00 -0400 O.00056691 RCKT Form 144 ROCKET PHARMACEUTICALS, Filed by: Militello John http://www.streetinsider.com/SEC+Filings/Form++144++++++++ROCKET+PHARMACEUTICALS%2C++++++++++++++++Filed+by%3A+Militello+John/26943923.html si-local-file:///var/storage/secattach/20260818/26943923.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++ROCKET+PHARMACEUTICALS%2C++++++++++++++++Filed+by%3A+Militello+John/26943923.html Tue, 18 Aug 2026 15:44:00 -0400 O.00056691 RCKT Form 4 ROCKET PHARMACEUTICALS, For: Aug 13 Filed by: Shah Gaurav http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+13++Filed+by%3A+Shah+Gaurav/26939088.html si-local-file:///var/storage/secattach/20260817/26939088.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+13++Filed+by%3A+Shah+Gaurav/26939088.html Mon, 17 Aug 2026 17:52:00 -0400 O.00056691 RCKT Form 4 ROCKET PHARMACEUTICALS, For: Aug 13 Filed by: Shah Gaurav http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+13++Filed+by%3A+Shah+Gaurav/26939088.html si-local-file:///var/storage/secattach/20260817/26939088.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+13++Filed+by%3A+Shah+Gaurav/26939088.html Mon, 17 Aug 2026 17:52:00 -0400 O.00056691 RCKT Form 4 ROCKET PHARMACEUTICALS, For: Aug 13 Filed by: Wilson Martin http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+13++Filed+by%3A+Wilson+Martin/26939084.html si-local-file:///var/storage/secattach/20260817/26939084.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+13++Filed+by%3A+Wilson+Martin/26939084.html Mon, 17 Aug 2026 17:50:00 -0400 O.00056691 RCKT Form 4 ROCKET PHARMACEUTICALS, For: Aug 13 Filed by: Wilson Martin http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+13++Filed+by%3A+Wilson+Martin/26939084.html si-local-file:///var/storage/secattach/20260817/26939084.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+13++Filed+by%3A+Wilson+Martin/26939084.html Mon, 17 Aug 2026 17:50:00 -0400 O.00056691 RCKT Form 4 ROCKET PHARMACEUTICALS, For: Aug 11 Filed by: Chaudhuri Sarbani http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+11++Filed+by%3A+Chaudhuri+Sarbani/26921332.html si-local-file:///var/storage/secattach/20260813/26921332.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+11++Filed+by%3A+Chaudhuri+Sarbani/26921332.html Thu, 13 Aug 2026 16:16:00 -0400 O.00056691 RCKT Form 4 ROCKET PHARMACEUTICALS, For: Aug 11 Filed by: Chaudhuri Sarbani http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+11++Filed+by%3A+Chaudhuri+Sarbani/26921332.html si-local-file:///var/storage/secattach/20260813/26921332.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+11++Filed+by%3A+Chaudhuri+Sarbani/26921332.html Thu, 13 Aug 2026 16:16:00 -0400 O.00056691 RCKT Form 4 ROCKET PHARMACEUTICALS, For: Aug 11 Filed by: Stevens Christopher James http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+11++Filed+by%3A+Stevens+Christopher+James/26921346.html si-local-file:///var/storage/secattach/20260813/26921346.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+11++Filed+by%3A+Stevens+Christopher+James/26921346.html Thu, 13 Aug 2026 16:16:00 -0400 O.00056691 RCKT Form 4 ROCKET PHARMACEUTICALS, For: Aug 11 Filed by: Stevens Christopher James http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+11++Filed+by%3A+Stevens+Christopher+James/26921346.html si-local-file:///var/storage/secattach/20260813/26921346.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++ROCKET+PHARMACEUTICALS%2C+++For%3A+Aug+11++Filed+by%3A+Stevens+Christopher+James/26921346.html Thu, 13 Aug 2026 16:16:00 -0400 O.00056691 RCKT Form 144 ROCKET PHARMACEUTICALS, Filed by: Wilson Martin http://www.streetinsider.com/SEC+Filings/Form++144++++++++ROCKET+PHARMACEUTICALS%2C++++++++++++++++Filed+by%3A+Wilson+Martin/26920623.html si-local-file:///var/storage/secattach/20260813/26920623.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++ROCKET+PHARMACEUTICALS%2C++++++++++++++++Filed+by%3A+Wilson+Martin/26920623.html Thu, 13 Aug 2026 16:04:00 -0400 O.00056691 RCKT